La diabetes mellitus tipo 2 (DM2), por su elevada prevalencia, número de discapacidades y alto coste económico, constituye una de las enfermedades crónicas con mayor impacto para el individuo, los sistemas sanitarios y la sociedad. El abordaje multifactorial y el manejo de la hiperglucemia corresponden, fundamentalmente, al ámbito de la atención primaria.
Publicaciones Similares
Artículo Tiroides y embarazo y posparto
PorSadenoEstá disponible para descarga el artículo sobre Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum, de la Asociación Americana de Tiroides. Descárgalo aquí
Guidelines Osteoporosis
PorSadenoTreatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update from the American College of Physicians Descarga aquí el artículo
Evolocumab and Clinical Outcomes in Patients with Card. Disease
PorSadenoDescargue el artículo completo ABSTRACT BACKGROUND Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain. METHODS We conducted a randomized, double-blind, placebo-controlled trial involving 27,564 patients with atherosclerotic cardiovascular disease and LDL cholesterol levels…
Evidencias de los nuevos tratamientos para el colesterol
PorSadenoClinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial LDL cholesterol is a well established risk factor for atherosclerotic cardiovascular disease. How much one should or safely can lower this risk factor remains debated. We aimed to explore the relationship between progressively lower…
AACE/ACE Consensus Statement
PorSadenoCONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2017 EXECUTIVE SUMMARY Autores: Alan J. Garber, MD, PhD, FACE1; Martin J. Abrahamson, MD2; Joshua I. Barzilay, MD, FACE3; Lawrence Blonde, MD, FACP, FACE4; Zachary T. Bloomgarden, MD, MACE5; Michael A. Bush, MD6; Samuel…
Standards or Medical Care in Diabetes 2017
PorSadenoConsulta aquí el artículo Standards or Medical Care in Diabetes 2017, publicado por la American Diabetes Association
